Duloxetine Capsule, Delayed Release
Product Images NDC 68001-596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68001-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Duloxetine Dr 20mg 60 Count Paithan (Duloxetine 20mg)

Duloxetine Dr 20mg 60 Count Paithan (Duloxetine 20mg)
FDA Label Image

Figure1 (Duloxetine Fig1)

Figure1 (Duloxetine Fig1)
FDA Label Image

Figure10 (Duloxetine Fig10)

Figure10 (Duloxetine Fig10)
FDA Label Image

Figure2 (Duloxetine Fig2)

Figure2 (Duloxetine Fig2)
The text describes a graph showing the proportion of patients with relapse over time. The graph compares the treatment of a placebo to the treatment of duloxetine. The x-axis represents the time from randomization to relapse in days, ranging from 0 to 300. The y-axis represents the proportion of patients with relapse, ranging from 0.0 to 10. The graph displays data points for different time intervals and treatment options.*
FDA Label Image

Figure3 (Duloxetine Fig3)

Figure3 (Duloxetine Fig3)
FDA Label Image

Figure4 (Duloxetine Fig4)

Figure4 (Duloxetine Fig4)
Percentage of Patients Improved: This text appears to provide information about the percentage of patients who experienced improvement. However, due to the presence of non-English characters and unclear formatting, the exact details are not discernible. Therefore, a more specific description cannot be generated.*
FDA Label Image

Figure5 (Duloxetine Fig5)

Figure5 (Duloxetine Fig5)
FDA Label Image

Figure6 (Duloxetine Fig6)

Figure6 (Duloxetine Fig6)
FDA Label Image

Figure8 (Duloxetine Fig8)

Figure8 (Duloxetine Fig8)
FDA Label Image

Figure9 (Duloxetine Fig9)

Figure9 (Duloxetine Fig9)
Not available.*
FDA Label Image

Structure (Duloxetine Structure)

Structure (Duloxetine Structure)
FDA Label Image

Duloxetine Dr Capsules 20mg 60 Count Bharuch Site (Image 02)

Duloxetine Dr Capsules 20mg 60 Count Bharuch Site (Image 02)
FDA Label Image

Duloxetine Dr Capsules 30mg 30 Count Paithan (Image 03)

Duloxetine Dr Capsules 30mg 30 Count Paithan (Image 03)
FDA Label Image

Duloxetine Dr Cap 30mg 30 Count Bharuch Site (Image 04)

Duloxetine Dr Cap 30mg 30 Count Bharuch Site (Image 04)
Not available.*
FDA Label Image

Duloxetine Dr Capsules 40mg 30 Count Paithan (Image 05)

Duloxetine Dr Capsules 40mg 30 Count Paithan (Image 05)
FDA Label Image

Duloxetine Dr Capsules 40mg 30 Count Bharuch Site (Image 06)

Duloxetine Dr Capsules 40mg 30 Count Bharuch Site (Image 06)
FDA Label Image

Duloxetine Dr Cap 60mg 30 Count Paithan (Image 07)

Duloxetine Dr Cap 60mg 30 Count Paithan (Image 07)
FDA Label Image

Duloxetine Dr Capsules 60mg 30 Count Bharuch Site (Image 08)

Duloxetine Dr Capsules 60mg 30 Count Bharuch Site (Image 08)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.